NASDAQ:ATOS

Atossa Genetics Stock Predictions

Healthcare > Biotechnology

Buy ATOS

*Your capital is at risk

$4.70

-0.150 (-3.09%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

ATOS Prediction Chart

ATOS Predictions History

Latest community submissions for ATOS.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Mar 8, 2018	$0.694 -99.54%	$0.83	V	83.60%	0
David.J.Rushton.19711	Mar 8, 2018	$0.765 -99.49%	$0.83	X	92.20%	0
Jason.Moats.21032	Mar 8, 2018	$0.690 -99.54%	$0.83	V	83.10%	0
Nick.Berrie.19598	Mar 8, 2018	$0.719 -99.52%	$0.83	V	86.60%	0
Adi	Mar 8, 2018	$0.677 -99.55%	$0.83	V	81.60%	0
Kazi.Ahmed.21261	Mar 8, 2018	$0.224 -99.85%	$0.83	V	27.00%	0
Paul.Otradovec.21239	Mar 7, 2018	$0.740 -99.41%	$0.700	X	94.30%	0
Jason.Moats.21032	Mar 7, 2018	$0.710 -99.44%	$0.700	X	98.60%	1
Justin @Justin.11298	Mar 7, 2018	$0.770 -99.39%	$0.700	X	90.00%	0
JS Pro	Mar 6, 2018	$0.682 -99.47%	$0.720	V	94.70%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ATOS with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ATOSSA GENETICS INC.

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by